Lumen stent and stent system

By setting the development component and restraint position on the aortic coated stent, the problems of poor adhesion and internal leakage of the distal end of the stent caused by the semi-release structure are solved, and the accurate release and adhesion of the stent is achieved, improving the safety of the surgery and success rate.

CN221932260UInactive Publication Date: 2024-11-01LIFETECH SCI (SHENZHEN) CO LTD
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202323597479.5
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-12-27
Publication Date
2024-11-01
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

During the implantation of aortic aneurysm and aortic dissection, the semi-release structure may lead to poor adhesion of the distal center of the stent, which in turn causes internal leakage, especially during the retraction of the limit rod, which makes the stent easy to Uneven folds and gap formation occur, affecting the complete release and anchoring of the stent.

Method used

A lumen bracket is designed, including a bracket body, a semi-release structure and a development assembly. Through the cooperation of the binding unit and the binding position, the development assembly is used to indicate the position of the binding position, ensuring that the bracket avoids the limit rod passing through in the semi-release state. Pass the small curved side of the vessel, thereby preventing internal leakage of the distal end, and achieving accurate release and adherence of the stent through adjustment of the restraint position.

Benefits of technology

Effectively avoiding the second area through which the stent is passed by the limiting rod in the semi-release state, preventing internal leakage of the distal end, and ensuring complete release and adherence of the stent, improving the safety of the surgery and Success rate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221932260U_ABST
    Figure CN221932260U_ABST
Patent Text Reader

Abstract

The utility model relates to a luminal stent, the luminal stent includes stent main part, semi-release structure and developing subassembly, the semi-release structure includes restraint unit and restraint position, the luminal stent includes first area and second area along the circumferential direction, is defined in the state that the luminal stent naturally expands, and the first area and the second area are located in the first area and the second area. The area, capable of being strided by the binding unit in the circumferential direction, of the lumen stent is a first area, and the area, incapable of being strided by the binding unit in the circumferential direction, of the lumen stent is a second area; the binding position is arranged in the second area, and the developing assembly is used for indicating the position of the binding position in the circumferential direction. The developing assembly is used for indicating the position of the binding position in the circumferential direction, the situation that the second area penetrated by the limiting rod is placed on the small bending side of the blood vessel when the lumen stent is in the semi-release state to be relieved can be avoided, and therefore inner leakage of the telecentric end is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model belongs to the technical field of medical equipment, and in particular relates to a lumen support and a support system. Background Art

[0002] Aortic aneurysm and aortic dissection are currently serious diseases that endanger human life safety. If not actively treated, the aortic aneurysm and dissection will continue to grow and eventually rupture, causing serious complications and death. With the increasing number of patients with hypertension, hyperlipidemia and hyperglycemia, the incidence of aortic aneurysm and aortic dissection is also increasing significantly. Traditional open surgery for aortic aneurysm and aortic dissection is traumatic, has a high mortality rate, a long operation time, a high incidence of postoperative complications and high surgical difficulty. Endovascular treatment has the characteristics of less trauma, fewer postoperative complications, shorter operation time and lower surgical difficulty, and has gradually become the main method for treating aortic aneurysm and aortic dissection. By implanting a covered stent in the aorta, the vascular lesions are isolated outside the covered stent, and the blood flow is restricted to flow through the inside of the covered stent, thereby achieving the purpose of protecting the blood vessels.

[0003] During the implantation of covered stents, it is often the case that the stent is partially attached to the wall but not fully released, which can easily lead to the "wind bag effect". The wind bag effect refers to the situation where the proximal end of the stent is attached to the wall, but the distal end has not been released, thus blocking the blood passage. As the heart continues to pump blood over time, more and more blood is blocked at the location of the stent, causing the stent to appear like a bulging pocket. The formation of the "wind bag effect" is very dangerous for surgery, because the blood circulation is blocked, the heart continues to pump blood, causing blood pressure to continue to rise, blood vessels to rupture, and the heart to be overloaded, which can seriously lead to the patient's death. The formation of the "wind bag effect" can easily lead to the displacement of the stent, failure to release the stent to the lesion site, or insufficient anchoring area, resulting in surgical failure.

[0004] To solve the above problems, a semi-release structure can be set on the aortic stent graft to gradually release the stent to avoid the "wind bag effect". In addition, when the stent is not attached to the wall, the axial position can be slightly adjusted to increase the accuracy of the stent release to the lesion. However, in the process of delivering the main thoracic stent, since the delivery guide wire is close to the greater curvature 901 of the blood vessel, if the limit rod 73 is located on the lesser curvature 902 of the blood vessel, Figure 1 As shown, when the limit rod 73 is withdrawn to release the semi-restraint and completely release the stent, on the one hand, the withdrawal of the limit rod is likely to cause the proximal end of the stent on the small curve side to shift toward the distal end, so that the proximal end is poorly attached to the wall after the coated stent is completely released, and then causes internal leakage of the proximal end; on the other hand, especially for the distal end of the small curve side of the stent, it will be pressed toward the direction of the large curve side by the limit rod before the withdrawal of the limit rod is completed, such as Figure 1-2As shown in FIG. 1 , the shape of the distal end stent before release is affected. After the stent is released, the distal end of the stent (the part pressed by the local position limit rod) is prone to incomplete expansion, which easily forms uneven wrinkles at this location, resulting in a large gap between the uneven wrinkles and the blood vessel, such as Figure 3 As shown, severe cases will cause internal leakage at the distal end of the stent. Utility Model Content

[0005] A technical problem solved by the utility model is how to provide a luminal stent to prevent the semi-constrained structure from causing poor wall adhesion of the distal end of the luminal stent and resulting in internal leakage.

[0006] The utility model provides a luminal stent, which includes a stent body, a semi-release structure and a developing component, the semi-release structure includes a restraining unit and a restraining position, the luminal stent includes a first area and a second area along the circumferential direction, and it is defined that when the luminal stent is naturally expanded, the area of ​​the luminal stent that can be crossed by the restraining unit in the circumferential direction is the first area, and the area that cannot be crossed by the restraining unit in the circumferential direction is the second area; the restraining position is set in the second area, and the developing component is used to indicate the position of the restraining position in the circumferential direction.

[0007] In one embodiment, the first region has a first sub-region that is centrally symmetrical to the second region, and the developing assembly includes a first developing member.

[0008] The first developing member is disposed in the second area, and a central angle α between an axial line where the first developing member is located and an axial line where the restraining position is located satisfies: 0°≤α≤45°;

[0009] Or, the first developing member is disposed in the first sub-region, and a central angle α1 between an axial line where the first developing member is located and an axial line where the restraining position is located satisfies: 135°≤α1≤180°;

[0010] Or the luminal support includes a second developing member, and a central angle α2 corresponding to an axial line where the second developing member is located and an axial line where the restraining position is located satisfies: 45°≤α2≤135°, and the second developing member is a non-axially symmetrical structure.

[0011] In one embodiment, the ratio of the central angle corresponding to the first area in the circumferential direction to the central angle corresponding to the second area in the circumferential direction is in the range of 1:1 to 4:1, and the central angle corresponding to the second area in the circumferential direction is defined as β, then β satisfies: 72°≤β≤180°; when β satisfies: 90°<β≤180°, the restraint position is set within the area range of ±45° of the angular mean line of the second area; when β satisfies: 72°≤β≤90°, the restraint position is set in the second area.

[0012] In one of the embodiments, the restraining position includes at least one limiting member, and when the endoluminal stent is radially compressed to a semi-restrained state, the restraining unit can pass through the limiting member;

[0013] At least one of the limiting members is on the same axial line as the first developing member;

[0014] Alternatively, at least one of the limiting members is closer to a middle position of the second region in the circumferential direction relative to the first developing member.

[0015] In one embodiment, there are multiple limit members, including a first limit member and a second limit member, and the circumferential deflection of the first limit member relative to the second limit member is less than or equal to 10°.

[0016] In one embodiment, the luminal stent also includes a coating covering the stent body, the developing assembly includes a first developing member, the first developing member is arranged in the second region, and the central angle between the axial line where the first developing member is located and the axial line where the restraining position is located is less than or equal to 45°; the luminal stent includes a second developing member, the second developing member is arranged on an axial line rotated 90° circumferentially from the first developing member, the first developing member is arranged at the proximal end of the stent body or the coating, and / or the second developing member is arranged at the distal end of the stent body or the coating.

[0017] In one embodiment, the first region further includes a first sub-region that is centrally symmetrical to the second region, and the endoluminal support further includes a third developing member, and the circumferential position of the third developing member is centrally symmetrical to the position of the first developing member along the circumferential direction.

[0018] In one embodiment, the first developing member and the third developing member have different shapes, and the second developing member is an axially symmetrical structure or a non-axially symmetrical structure;

[0019] Alternatively, the first developing member and the third developing member have the same shape, and the second developing member is a non-axially symmetrical structure.

[0020] The utility model also provides a stent system, comprising a delivery device and a luminal stent as described above, characterized in that the delivery device comprises a sheath core assembly and a limiting rod, the restraining unit comprises a beam line and a locking assembly, the limiting rod can extend along the restraining position in the axial direction of the luminal stent, so that it can movably pass through the locking assembly to compress the luminal stent into the circumference formed by the beam line, so that the luminal stent is restricted to a semi-restrained state.

[0021] In one of the embodiments, the semi-release structure further includes a limiting ring, which is circumferentially arranged on the bracket body, and the restraining unit passes through the limiting ring circumferentially, so that the limiting ring limits the axial position of the restraining unit.

[0022] A technical effect of an embodiment of the utility model is that the utility model can avoid the second area passed by the limiting rod being placed on the lesser curvature of the blood vessel when the luminal stent is in a semi-released state to be released, thereby avoiding internal leakage of the distal end, by arranging a developing component to indicate the position of the restraining position in the circumferential direction. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 A schematic diagram showing that the circumferential position of the restraining position of the luminal stent cannot be identified in the prior art, which may lead to the restraining position being released on the lesser curvature side;

[0024] Figure 2 for Figure 1 Cross-section view in the AA direction;

[0025] Figure 3 for Figure 1 Schematic diagram of the wall adhesion of the distal end of the luminal stent in the AA direction after the luminal stent is completely released;

[0026] Figure 4 This is a schematic diagram of the structure of the luminal stent provided by the utility model (natural expansion state);

[0027] Figure 5 for Figure 4 Rotate 90° around the circumference (from Figure 4 The structure diagram of the posterior luminal stent is shown as a right side (rotated 90° counterclockwise looking toward the left);

[0028] Figure 6 for Figure 5 The middle is a schematic diagram of the circumferential region of the cross-luminal stent of the restraining unit from the left to the right (natural expansion state);

[0029] Figure 7 for Figure 6 Schematic diagram of the division of the first area and the second area under the viewing angle;

[0030] Figure 8 for Figure 7 Schematic diagram of the ±45° region M of the angular mean line of the second region;

[0031] Fig. 9 for Figure 6 Schematic diagram of the partitioning of the second area and the first sub-area under the viewing angle;

[0032] Fig.10This is a structural schematic diagram of the endoluminal stent (natural expansion state) provided by the utility model from another perspective;

[0033] Fig.11 for Fig.10 A partial structural diagram of (showing the limiter);

[0034] Fig.12 This is a schematic diagram of the structure of the luminal stent provided by the utility model in a semi-constrained state;

[0035] Fig.13 for Fig.12 A partial structural schematic diagram of the embodiment (showing the cooperation between the restraining unit and the limiting rod);

[0036] Fig.14 The support system provided by the utility model is transported to a predetermined position;

[0037] Fig.15 After the sheath of the stent system provided by the utility model is withdrawn, the luminal stent is in a semi-restrained state;

[0038] Fig.16 for Fig.15 Enlarged view of point E in the middle;

[0039] Fig.17 This is a schematic diagram of the endoluminal stent provided by the present invention being completely released at a predetermined position.

[0040] 100, luminal stent; 10, stent body; 111, wave-shaped ring; 111a, wave crest; 111b, wave trough; 111c, wave rod;

[0041] 20. Lamination;

[0042] 30. Semi-release structure; 31. Constraint unit; 311. Constraint line; 312. Locking buckle assembly; 3121. First locking buckle; 3122. Second locking buckle; 32. Position limiting ring buckle; 33. Constraint position; 34. Middle fixing buckle;

[0043] 40. developing member; 41. first developing member; 42. second developing member; 43. third developing member;

[0044] 100a, first region; 100b, second region; 100c, first sub-region;

[0045] 50. Naked wave circle;

[0046] 70. Delivery device; 71. Sheath core assembly; 72. Sheath tube; 73. Limit rod

[0047] L1, the axial line where the first developing member is located; L2, the axial line where the restraining position is located DETAILED DESCRIPTION

[0048] In order to facilitate the understanding of the present invention, the present invention will be described more comprehensively with reference to the relevant drawings. The drawings provide preferred embodiments of the present invention. However, the present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the disclosure of the present invention more thoroughly and comprehensively understood.

[0049] It should be noted that when an element is referred to as being "fixed to" another element, it may be directly on the other element or there may be a central element. When an element is considered to be "connected to" another element, it may be directly connected to the other element or there may be a central element at the same time. The terms "inside", "outside", "left", "right" and similar expressions used herein are for illustrative purposes only and do not represent the only implementation method.

[0050] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art in the technical field of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.

[0051] "Axial" generally refers to the length direction of the medical device when it is delivered, and "radial" generally refers to the direction of the medical device perpendicular to its "axial" direction. Based on this principle, the "axial" and "radial" directions of any component of the medical device are defined. In addition, in the field of interventional medicine, the end of the luminal stent closest to the heart after release is usually defined as the proximal end, and the end farthest from the heart is defined as the distal end.

[0052] The utility model provides a luminal stent 100, such as Figure 4-17 As shown, the luminal stent 100 includes a stent body 10, a coating 20, a semi-release structure 30, a restraining position 33, a developing member 40 and a bare wave ring 50. The stent body 10 includes a plurality of wave-shaped rings 111 spaced apart in the axial direction, each wave-shaped ring 111 includes a plurality of wave crests 111a and wave troughs 111b and a plurality of connecting rods respectively connecting adjacent wave crests 111a and wave troughs 111b. The coating 20 covers the plurality of wave-shaped rings 111 of the stent body 10 to form a hollow luminal structure. The distal end of the bare wave ring 50 is connected to the proximal end of the coating 20. Figure 4-5As shown; in other embodiments, the bare wave ring 50 may not be provided, and the semi-bound and loaded directly into the loading position formed between the sheath core assembly 71 and the sheath tube 72, which is not limited here. It can be understood that the multiple wave-shaped rings 111 can be of the same or similar wave shape, or can be wave-shaped rings with different wave shapes. The wave shape of the wave-shaped ring 111 can be set as needed, and the number of wave shapes in each wave-shaped ring 111, the wave height, etc. can be set as needed.

[0053] like Figure 4-5 As shown, the semi-release structure 30 includes a restraining unit 31, a limiting ring buckle 32 and a limiting member 330, wherein the restraining unit 31 passes through the limiting ring buckle 32 in the circumferential direction, wherein the restraining unit 31 includes a restraining line 311 and a locking assembly 312, wherein the locking assembly 312 is connected to the restraining line 311 and is formed at both ends of the restraining line 311. In this embodiment, the restraining line 311 is a double-stranded line, and the locking assembly 312 is the folded end portion of the restraining line 311. In other embodiments, the restraining line 311 may also be two sections of double-stranded lines extending from the middle axial line of the first region 100a toward the circumferential ends of the first region 100a, respectively. An intermediate fixing buckle 34 is provided on the middle axial line of the first region 100a, and the two sections of double-stranded lines extend from the intermediate fixing buckle 34 in the circumferential direction toward the direction close to the second region 100b to the edge of the first region 100a, respectively, as shown in FIG. Figure 6-9 As shown, disposing a middle fixing buckle 34 on the middle axial line of the first region 100a can make the binding of the radial line 311 more stable.

[0054] like Figure 4-5As shown, the limiting ring buckle 32 is circumferentially arranged on the bracket body 10 and can be fixed on the corrugated ring 111 or the coating 20. In this embodiment, a plurality of limiting ring buckles 32 are circumferentially fixed at intervals in the middle of part of the wave rod 111c of the corrugated ring 111 (a wave peak 111a is formed at the proximal end point between two adjacent wave rods 111c, and a limiting ring buckle 32 is arranged on at least one wave rod 111c between two adjacent wave rods 111c). Each beam line 311 passes through the plurality of limiting ring buckles 32 on the corresponding annular corrugated object in sequence along the circumferential direction, so that the limiting ring buckle 32 limits the beam line 311 to the middle area in the axial direction of the corrugated ring 111, thereby preventing the corrugated ring 111 from being subjected to uneven radial constraint force, thereby facilitating the restraining unit 31 to circumferentially constrain the bracket body 10. The locking buckle assembly 312 includes a first locking buckle 3121 and a second locking buckle 3122 connected at both ends of the bundle warp line. The first locking buckle 3121 and the second locking buckle 3122 are both annular ends formed by folding the bundle warp line 311. After the luminal stent 100 is radially compressed, the first locking buckle 3121 passes through the limiting piece 330 of the second area 100b, and the limiting rod 73 of the conveying device 70 passes through the first locking buckle 3121 axially to limit the first locking buckle 3121 at the position of the limiting piece 330. The limiting rod 73 also needs to pass through the second locking buckle 3122. After the luminal stent 100 is bundled to a semi-released state, it is radially compressed in the sheath 72.

[0055] like Figure 6-9 Combination Figure 10-13 As shown, the semi-release structure 30 can be used to constrain the circumference of the stent body 10. In this embodiment, the semi-release structure 30 is arranged on the outer surface of the luminal stent 100. Figure 6 When the sheath 72 is withdrawn, the luminal stent 100 compressed in the delivery device 70 is released from the sheath 72. Due to the radial constraint of the semi-release structure, the luminal stent 100 is in a semi-release state, as shown in FIG. Figure 12-13 As shown, at this time, the outer diameter of the luminal stent 100 is smaller than the inner diameter of the blood vessel due to radial constraint, so it does not fit the inner wall of the blood vessel. Therefore, in the semi-released state of the luminal stent 100, the circumferential position of the restraint position 33 can still be determined according to the position of the developing assembly, so as to fine-tune the axial and circumferential positions of the luminal stent 100. After the axial and circumferential positions are adjusted to the expected positions, the radial constraint of the semi-constrained structure is released, and the luminal stent 100 is changed from the semi-released state to the fully expanded state and attached to the inner wall of the blood vessel.

[0056] in, Figure 4-9 The front, back, left and right sides of the bracket shown in the figure are in opposite positions to the front and back, left and right of the patient, and the figure is only for the convenience of explaining the position of the bracket. Figure 4 The side that can be seen (i.e. facing the reader on the paper) is the back side, corresponding to Figure 5 Below (back side), Figure 4 The side that cannot be seen (i.e. the back of the paper) is the front side, corresponding to Figure 5 Similarly, Figure 5 The side that can be seen (i.e. facing the reader on the paper) is the right side, corresponding to Figure 4 Above (right side), Figure 5 The side that cannot be seen (i.e. the back of the paper) is the left side, corresponding to Figure 4 Below (left side) in the .

[0057] like Figure 6-9 As shown, the luminal stent 100 includes a first area 100a and a second area 100b along the circumferential direction, wherein it is defined that when the luminal stent 100 is in a naturally expanded state, the area of ​​the luminal stent 100 that can be crossed by the restraining unit 31 in the circumferential direction is the first area 100a, and the area that cannot be crossed by the restraining unit 31 in the circumferential direction is the second area 100b; the developing assembly 40 includes a first developing member 41, and the first developing member 41 is arranged in the second area 100b, and the central angle α between the axial line L1 where the first developing member 41 is located and the axial line L2 where the restraining position 33 is located satisfies: 0°≤α≤45°, as shown in FIG. Figure 7 As shown; in other embodiments, as Fig. 9 As shown, the first area 100a includes a first sub-area 100c that is symmetrical to the center of the second area 100b, and the central angle α1 between the axial line L1 where the first developing member 41 is located and the axial line L2 where the restraining position 33 is located satisfies: 135°≤α1≤180°; wherein the maximum value of α1 is 180°, so Fig. 9 Only the first developing member is shown to be located at a lower position in the first sub-region 100c, so that the angle α1 formed is Fig. 9 In the lower semicircle, in other embodiments, the first developing member can also be set at an upper position in the first sub-region 100c in the figure, so that the angle α1 formed is in the upper semicircle (figure omitted); the first developing member 41 can be set in the second region 100b or the first sub-region 100c to facilitate distinguishing the left and right sides of the luminal stent 100, and at the same time, the restraining position 33 is set on the same side or the opposite side of the first developing member 41, so that the first developing member 41 can be used to indicate the circumferential position of the restraining position 33.

[0058] Alternatively, the endoluminal stent 100 includes a second developing member 42, and a central angle α2 corresponding to an axial line where the second developing member 42 is located and an axial line L2 where the restraining position 33 is located satisfies: 45°≤α2≤135°. Figure 8 As shown, the second developing member 42 is a non-axially symmetrical structure to distinguish the front and rear positions of the luminal stent 100, so that the restraining position 33 is set on a specific side of the second developing member 42 (for example Figure 8The second developing member 42 can be used to indicate the position of the restraint position 33 in the circumferential direction, and the second region 100b penetrated by the limiting rod 73 can be prevented from being placed on the lesser curvature of the blood vessel when the luminal stent 100 is in the semi-released state to be released, thereby preventing endoleakage at the distal end. In addition, the problem of poor wall adhesion caused by the displacement of the proximal end of the stent lesser curvature due to the withdrawal of the limiting rod can be avoided, thereby preventing endoleakage at the proximal end.

[0059] The first developing component 41 is arranged at the proximal end of the stent body 10 or the coating 20. Setting the developing component at the proximal end of the stent body 10 or the coating 20 can simultaneously indicate the position of the proximal end of the stent; the second developing component 42 is arranged at the proximal end or the distal end of the luminal stent 100. The second developing component 42 can be arranged on the stent body 10 or the coating 20. Only the first developing member 41 may be provided to distinguish the first side and the second side of the luminal stent 100; only the second developing member 42 may be provided to distinguish the front and the back of the luminal stent 100. When only the second developing member 42 is provided, the second developing member 42 needs to be a non-axially symmetrical structure to facilitate the distinction between the front and the back of the luminal stent 100; the first developing member 41 and the second developing member 42 may also be provided at the same time. In other embodiments, the luminal stent 100 may further include a third developing member 43, the first developing member 41 is provided in the second region 100b, the third developing member 43 is symmetrical with the first developing member 41 along the circumferential direction, and / or the second developing member 42 is rotated 90° along the circumferential direction from the first developing member 41, wherein the second developing member 42 may be provided at the proximal end or the distal end of the coating 20 by suturing.

[0060] When the first developing member 41 and the third developing member 43 have different shapes, the left and right sides of the luminal stent 100 can be distinguished, and the second developing member 42 can be an axially symmetrical structure or a non-axially symmetrical structure; when the first developing member 41 and the third developing member 43 have the same shape, the second developing member 42 needs to be set as a non-axially symmetrical structure to distinguish the front and back of the luminal stent 100, and when the luminal stent 100 is implanted in a blood vessel, the second area 100b can be attached to the greater curvature of the blood vessel to release the semi-release structure 30 of the luminal stent 100, so that the luminal stent 100 is completely released. In one embodiment, the non-axially symmetrical structure of the second developing member 42 can be a recognizable pattern of a non-axially symmetrical shape including a closed structure such as "6", "G", "9", etc.

[0061] like Figure 4-5 Combination Figure 10-13As shown, in this embodiment, the luminal stent 100 includes a first developing member 41, a second developing member 42 and a third developing member 43, the first developing member 41 and the third developing member 43 are arranged at the proximal end of the coating 20, the second developing member 42 is arranged at the distal end of the coating 20, and each developing member can be fixed on the coating 20 by suturing. The first developing member 41 and the second developing member 42 are of different shapes. The first developing member 41 is arranged in the second area 100b. The first developing member 41 can be arranged in an "8" shape. A plurality of limiting members 330 form an axially bound position 33, and are sequentially arranged on the middle axial line of the second area 100b, thereby forming an axial line L2 where the bound position 33 is located. In this embodiment, the first developing member is also arranged on the middle axial line of the second area 100b, so the middle axial line of the second area 100b is the axial line L1 where the first developing member 41 is located, that is, the axial line L1 where the first developing member 41 is located and the axial line L2 where the bound position 33 is located are on the same axial line, that is, in this embodiment, α=0°, such as Fig.10 The first developing member 41 and the limiting member 330 are arranged on the same axial line (or the first developing member 41 is deflected by no more than 10° relative to the axial line where the limiting member 330 is located), and the first developing member 41 is sutured to the proximal end of the coating 20; the limiting member 330 is arranged as a suture thread buckle, which is sutured to the coating 20 around the middle position of the wave rod 111c of the corresponding wave-shaped ring 111 or is directly sutured to the coating 20 beside the middle position of the wave rod 111c without being sutured around the wave rod 111c, and a gap is left for the binding unit 31 to pass through. The third developing member 43 can be set to a "0" shape and be symmetrical with the first developing member 41 along the circumferential center. The different structures of the first developing member 41 and the second developing member 42 can distinguish the left and right directions (the first side and the second side) of the luminal stent 100; the second developing member 42 can be set to a "0" shape, and the second developing member 42 is arranged at the distal end of the coating 20 of the luminal stent 100, and the second developing member 42 is rotated 90° along the circumferential direction from the first developing member 41. Figure 4 Under the development angle shown, the second development member 42 is located on the perpendicular midline of the line connecting the first development member 41 and the third development member 43, and can form a three-dimensional structure between the first development member 41 and the third development member 43, so as to facilitate the judgment of whether the distal end of the stent is evenly spread in the circumferential direction after the luminal stent 100 is fully released. In other embodiments, only the first development member 41 or only the second development member 42 of a non-axially symmetrical structure can be provided, and it is only necessary for the development component to indicate the position of the restraint position 33 in the circumferential direction, so that the luminal stent 100 in the semi-restrained state can be adjusted in the circumferential direction to fit the restraint position 33 to the greater curvature of the blood vessel, and no limitation is made here.

[0062] Generally, the two ends of the restraining unit 31 are releasably restrained to the restraining position 33, so that the semi-release structure 30 semi-constrains the stent body 10 in the circumferential direction. When a limiting rod 73 is provided in the conveying device 70 to limit the restraining unit 31, the limiting rod 73 is generally axially provided at the restraining position 33 in the second area 100b, so that the two ends of the beam line 311 are limited in the second area 100b, thereby compressing the radial direction of the luminal stent 100. In this embodiment, the locking components 312 at the two ends of the beam line 311 are close to each other at the middle position of the second area 100b, and the limiting rod 73 passes through the locking components 312 at the two ends to compress the corrugated ring 111 of the luminal stent 100. The limiting rod 73 passes through the locking components 312 at the two ends of the beam line 311 corresponding to each corrugated ring in turn, thereby compressing the radius of the luminal stent 100 as a whole to a semi-constrained state. The luminal stent 100 also includes a first side and a second side along the circumference, the first side and the second side each occupy 180° in the circumference, and the second area 100b is located within the range of ±45° area M of the angular mean line of the first side, wherein the first side of the luminal stent is located on the greater curvature side of the aortic arch when implanted in the blood vessel, and the second side is located on the lesser curvature side of the aortic arch when implanted in the blood vessel, and the setting of the developing component can be used to indicate the position of the restraint position 33 in the circumferential direction, so that the first side and the second side of the luminal stent 100 can be distinguished during the implantation of the luminal stent 100, and when the circumference of the luminal stent 100 is adjusted in the semi-released state, the restraint position 33 of the second area 100b can be made to correspond to the greater curvature side of the blood vessel, so that the luminal stent 100 can be released when the semi-released state is released. During the process, the second area 100b thereof is attached to the greater curvature of the blood vessel, so that the limiting rod 73 is attached to the greater curvature and withdrawn, to prevent the proximal end of the second side of the stent from shifting toward the distal end when the withdrawn limiting rod 73 is released from the semi-released state, thereby causing the proximal end of the coated stent 20 to be poorly attached to the wall after the stent is fully released, thereby causing internal leakage of the proximal end; on the other hand, it can also prevent the distal end of the second side of the luminal stent 100 from being pressed toward the greater curvature by the limiting rod 73 before the limiting rod 73 is completely withdrawn, so as to ensure that the distal end of the luminal stent 100 has a good shape in the semi-released state, to prevent the distal end of the second side of the luminal stent 100 from being easily unfolded incompletely after the stent is released, thereby avoiding the formation of uneven wrinkles, and further avoiding internal leakage of the distal end of the stent.

[0063] It is understandable that if the diameter of the circumscribed circle of the cross section of the luminal stent 100 is too large when it is in the semi-released state, the luminal stent 100 is easy to stick to the inner wall of the blood vessel in the semi-released state, which is not conducive to the axial and circumferential adjustment thereof; if the diameter of the circumscribed circle of the cross section of the luminal stent 100 is too small when it is in the semi-released state, even if the circumferential or axial position is adjusted, after the semi-released state is released, due to the large radial change of the stent, there may still be large circumferential and axial positioning deviations, making the semi-release structure 30 not work well. In this embodiment, the ratio of the diameter of the circumscribed circle of the cross section of the luminal stent 100 in the semi-released state to the diameter of the circumscribed circle of the cross section of the luminal stent 100 when it is naturally expanded is 0.5 to 0.8.

[0064] Since the circumference of the cross section in the semi-released state is the circumferential length of the beam line 311, the ratio of the circumscribed circle diameter of the cross section of the luminal stent 100 in the semi-released state to the circumscribed circle diameter of the cross section when the luminal stent 100 is naturally expanded is equal to the ratio of the central angle corresponding to the first region 100a in the circumferential direction to the 360-degree angle of the circumference. When the ratio of the circumscribed circle diameter of the cross section of the luminal stent in the semi-released state to the circumscribed circle diameter of the cross section when the luminal stent is naturally expanded is 0.5, the central angle corresponding to the first region in the circumferential direction is 180°; when the ratio of the circumscribed circle diameter of the cross section of the luminal stent in the semi-released state to the circumscribed circle diameter of the cross section when the luminal stent is naturally expanded is 0.8, the central angle corresponding to the first region in the circumferential direction is 288°, and the central angle corresponding to the second region in the circumferential direction is 72°. Define the central angle spanned by the second region 100b as β, such as Figure 7 As shown, the central angle corresponding to the circumference of the first area 100a is equal to 360°-β, wherein β satisfies: 72°≤β≤180°; when the β satisfies: 90°<β≤180°, the first developing member 41 is arranged within the range of ±45° region M of the angular average line of the second area 100b or the first sub-area 100c; when the α satisfies: 72°≤β≤90°, the first developing member 41 is arranged in the second area 100b or the first sub-area 100c to distinguish the first side and the second side of the luminal stent 100, and the limiting rod 73 in the second area 100b is closer to the middle position of the first side, so that when the luminal stent 100 is in a semi-released state, with the help of the indication of the developing assembly 40, the limiting rod 73 located at the restraining position 33 is closer to the greater curvature side of the blood vessel.

[0065] The restraining position 33 of the luminal stent includes at least one limit member 330, which can be used to limit the limit rod 73 in the restraining position. In this embodiment, the restraining position 33 of the luminal stent 100 includes multiple limit members, which are axially arranged in the second area 100b. The limit members are generally arranged in the range of ±45° area M of the angular mean line of the second area 100b. The circumferential distances of the locking components 312 at both ends of the bundle diameter line 311 are equal or approximately equal, so that when the luminal stent 100 is in a semi-released state, the limit rod 73 in the second area 100b is closer to the middle position of the greater bend of the blood vessel. When the luminal stent 100 is radially compressed to a semi-restrained state, one end of the restraining unit 31 can pass through the limit member, and then the limit rod 73 is passed through the locking components 312 at both ends of the restraining unit 31 in sequence. The number of limiters can be specifically determined according to the number of the stent corrugated rings 111 and the extent to which the semi-constraint is to be extended in the axial direction. A plurality of limiters are spaced axially to form the restraining position 33. The central angle between the axial line where the limiters are located and the axial line L1 where the first developing member 41 is located is α, and the limiters are circumferentially closer to the middle position of the second region 100b relative to the first developing member 41. When the luminal stent 100 is radially compressed and converged to a semi-released state, the locking assembly 312 at one end of the beam line 311 passes through the limiter at its corresponding position in the circumferential direction, and then the limiter rod 73 passes through the locking assembly 312, so that the limiter limits the circumferential position of the limiter rod 73, thereby limiting the limiter rod 73 at the position of the limiter, such as Fig.13 When α=0°, the limiting member and the first developing member 41 are on the same axial line L1, as shown in FIG. Figure 10-11 Combination Figure 12-13 As shown, a plurality of limit members are axially arranged on both sides of the middle axial line L1 of the second region 100b within a range of 10° on either side. In one embodiment, the limit member and the first developing member 41 are both located on the middle axial line of the second region 100b, so that the circumferential distances between the limit member and the locking components 312 at both ends of the beam line 311 are approximately equal, so that when the luminal support 100 is in a semi-released state, the compression state of the luminal support 100 is uniform and the semi-constrained state is more stable.

[0066] Multiple limit members can be arranged in sequence along the same axial line on each corrugated ring 111 or on the coating 20 corresponding to the middle position of its wave rod 111c, and can also be slightly deflected relatively, as long as it does not affect the uniform compression and release of the semi-constraint. No limitation is made here. The limit members include a first limit member and a second limit member. It is only necessary that the central angle of the axial line where any limit member (constraint position 33) is located and the axial line L1 where the first developing member 41 is located satisfies the aforementioned α, and the circumferential deflection of the first limit member relative to the second limit member is less than or equal to 10°, so that the limit rod 73 is roughly along the axial direction.

[0067] The utility model also provides a stent system, including a delivery device 70 and a luminal stent 100 as described above, wherein the delivery device 70 includes a sheath core assembly 71, a sheath tube 72 and a limiting rod 73, wherein the limiting rod 73 extends axially along the second region 100b and is movably connected to the locking assembly 312, and the luminal stent 100 is radially compressed in a loading interval formed between the sheath tube 72 and the sheath core assembly 71.

[0068] Taking the implantation of the main thoracic stent system as an example, Figure 14-17 As shown, when the stent system is delivered to a predetermined position, the sheath 72 is withdrawn, and the luminal stent 100 is not completely released to a semi-released state due to the effect of the semi-constrained structure, so as to prevent the wind bag effect, such as Fig.15 As shown, the axial position of the luminal stent 100 can also be fine-tuned to make the release position of the luminal stent 100 more accurate. At the same time, according to the position of the first developing member 41, the circumferential position of the luminal stent 100 is adjusted so that the side where the limiting rod 73 of the stent system is located is close to the greater curvature of the blood vessel, as shown in FIG. Figure 15-16 As shown, it can prevent the proximal end of the stent's small curve side from shifting toward the distal end due to the removal of the semi-constraint caused by the withdrawal of the limiting rod 73, thereby preventing internal leakage caused by poor adhesion of the proximal end of the luminal stent 100 to the wall; on the other hand, it can also prevent the limiting rod 73 from pressing against the distal end of the small curve side of the luminal stent 100 on the small curve side, and prevent the distal end of the small curve side of the luminal stent 100 from being in a state of being recessed toward the large curve side before the stent is released, thereby preventing the problem of uneven expansion of the distal end of the stent after the stent is completely released, and further preventing internal leakage of the distal end of the stent. After the limiting rod 73 is withdrawn, the semi-constraint state is released, and the luminal stent 100 is completely released. Fig.17 As shown, in this embodiment, when the luminal stent 100 is fully released, the perpendicular bisector L3 (i.e., the center line of the blood vessel) of the first developing member 41 and the third developing member 43 is defined, and it is also possible to determine whether the distal end of the luminal stent 100 is evenly deployed based on the position of the second developing member 42 relative to the perpendicular bisector L3 of the first developing member 41 and the third developing member 43.

[0069] In other embodiments, the limit rod 73 can also pass through the limit member, so that the limit member limits the limit rod 73 on the axial line where the limit member is located (i.e., the restraining position), and the limit rod 73 also passes through the first lock buckle 3121 and the second lock buckle 3122. At the same time, the first lock buckle 3121 and the second lock buckle 3122 are limited on the axial line where the limit member is located, and the contraction of the semi-restrained structure can also be achieved. No limitation is made here. It only needs at least one of the lock buckle assembly 312 or the limit rod 73 to pass through the limit member to realize that the setting position of the limit member is the restraining position 33.

[0070] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0071] The above-mentioned embodiments only express several implementation methods of the utility model, and the description is relatively specific and detailed, but it cannot be understood as limiting the scope of the utility model patent. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the utility model, which all belong to the protection scope of the utility model. Therefore, the protection scope of the utility model patent shall be based on the attached claims.

Claims

1. A luminal stent, characterized in that: The luminal stent includes a stent body, a semi-release structure and a developing component, the semi-release structure includes a restraining unit and a restraining position, the luminal stent includes a first area and a second area along the circumferential direction, it is defined that when the luminal stent is naturally expanded, the area of ​​the luminal stent that can be crossed by the restraining unit in the circumferential direction is the first area, and the area that cannot be crossed by the restraining unit in the circumferential direction is the second area; the restraining position is set in the second area, and the developing component is used to indicate the position of the restraining position in the circumferential direction.

2. The endoluminal stent according to claim 1, characterized in that: The first region has a first sub-region that is centrally symmetrical to the second region, and the developing assembly includes a first developing member. The first developing member is disposed in the second area, and a central angle α between an axial line where the first developing member is located and an axial line where the restraining position is located satisfies: 0°≤α≤45°; Or, the first developing member is disposed in the first sub-region, and a central angle α1 between an axial line where the first developing member is located and an axial line where the restraining position is located satisfies: 135°≤α1≤180°; Or the luminal support includes a second developing member, and a central angle α2 corresponding to an axial line where the second developing member is located and an axial line where the restraining position is located satisfies: 45°≤α2≤135°, and the second developing member is a non-axially symmetrical structure.

3. The endoluminal stent according to claim 2, characterized in that: The ratio of the central angle corresponding to the first area in the circumferential direction to the central angle corresponding to the second area in the circumferential direction is in the range of 1:1 to 4:1, and the central angle corresponding to the second area in the circumferential direction is defined as β, then β satisfies: 72°≤β≤180°; when β satisfies: 90°<β≤180°, the restraint position is set within the area range of ±45° of the angular mean line of the second area; when β satisfies: 72°≤β≤90°, the restraint position is set in the second area.

4. The endoluminal stent according to claim 2, characterized in that: The restraining position includes at least one limiting piece, and when the endoluminal stent is radially compressed to a semi-restrained state, the restraining unit can pass through the limiting piece; At least one of the limiting members is on the same axial line as the first developing member; Alternatively, at least one of the limiting members is closer to a middle position of the second region in the circumferential direction relative to the first developing member.

5. The endoluminal stent according to claim 4, characterized in that: There are multiple limit members, including a first limit member and a second limit member, and the deflection of the first limit member relative to the second limit member in the circumferential direction is less than or equal to 10°.

6. The endoluminal stent according to claim 1, characterized in that: The luminal stent also includes a coating covering the stent body, the developing assembly includes a first developing member, the first developing member is arranged in the second area, and the central angle between the axial line where the first developing member is located and the axial line where the restraining position is located is less than or equal to 45°; the luminal stent includes a second developing member, the second developing member is arranged on an axial line rotated 90° circumferentially from the first developing member, the first developing member is arranged at the proximal end of the stent body or the coating, and / or the second developing member is arranged at the distal end of the stent body or the coating.

7. The endoluminal stent according to claim 6, characterized in that: The first region further includes a first sub-region that is centrally symmetrical to the second region, and the endoluminal support further includes a third developing member, and the circumferential position of the third developing member is centrally symmetrical to the position of the first developing member along the circumferential direction.

8. The endoluminal stent according to claim 7, characterized in that: The first developing member and the third developing member have different shapes, and the second developing member is an axially symmetrical structure or a non-axially symmetrical structure; Alternatively, the first developing member and the third developing member have the same shape, and the second developing member is a non-axially symmetrical structure.

9. A stent system, comprising a delivery device and a luminal stent according to any one of claims 1 to 8, characterized in that: The delivery device includes a sheath core assembly and a limiting rod, the restraining unit includes a restraining wire and a locking assembly, the limiting rod can extend along the restraining position in the axial direction of the luminal stent, so that it can movably pass through the locking assembly to compress the luminal stent into the circumference formed by the restraining wire, so that the luminal stent is restricted to a semi-restrained state.

10. The support system according to claim 9, characterized in that: The semi-release structure further comprises a limiting ring buckle, which is circumferentially arranged on the bracket body, and the restraining unit passes through the limiting ring buckle along the circumferential direction, so that the limiting ring buckle limits the axial position of the restraining unit.

Citation Information

Cited By

  • Lumen stent and stent system

    CN120203865A

  • Lumen stent and stent system

    CN120203865B

  • Endoluminal stent and stent system

    WO2025139448A1